1
|
Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Nahit Sendur MA. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer. Future Oncol 2023; 19:727-736. [PMID: 37133230 DOI: 10.2217/fon-2022-1287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2023] Open
Abstract
Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Methods: The authors report retrospective real-life data for 600 patients with estrogen receptor- and/or progesterone receptor-positive and HER2-negative metastatic breast cancer who were treated with ribociclib and palbociclib in combination with letrozole. Results & conclusion: The results demonstrated that the combination of palbociclib or ribociclib with letrozole has similar progression-free survival and overall survival benefit in real life for the patient group with similar clinical features. Specifically, endocrine sensitivity may be a factor to be considered in the treatment preference.
Collapse
Affiliation(s)
- Seda Kahraman
- Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, 06800, Turkey
| | - Enes Erul
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06590, Turkey
| | - Mustafa Seyyar
- Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, 41000, Turkey
| | - Ozge Gumusay
- Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, 34750, Turkey
| | - Ertugrul Bayram
- Department of Medical Oncology, Cukurova University, Adana, 01330, Turkey
| | - Burcin Cakan Demirel
- Department of Medical Oncology, Pamukkale University Hospital, Denizli, 20160, Turkey
| | - Omer Acar
- Department of Medical Oncology, Manisa Celal Bayar University Hospital, Mersin, 45120, Turkey
| | - Sercan Aksoy
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06590, Turkey
| | | | - Elif Sahin
- Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, 41000, Turkey
| | - Devrim Cabuk
- Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, 41000, Turkey
| | - Gul Basaran
- Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, 34750, Turkey
| | - Semra Paydas
- Department of Medical Oncology, Cukurova University, Adana, 01330, Turkey
| | - Arzu Yaren
- Department of Medical Oncology, Pamukkale University Hospital, Denizli, 20160, Turkey
| | - Deniz Can Guven
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06590, Turkey
| | - Atike Pinar Erdogan
- Department of Medical Oncology, Manisa Celal Bayar University Hospital, Mersin, 45120, Turkey
| | - Umut Demirci
- Department of Medical Oncology, Ankara Memorial Hospital, Ankara, 06520, Turkey
| | - Alper Yasar
- Department of Medical Oncology, Marmara University Pendik Research & Application Hospital, Istanbul, 34899, Turkey
| | - İbrahim Vedat Bayoglu
- Department of Medical Oncology, Marmara University Pendik Research & Application Hospital, Istanbul, 34899, Turkey
| | - Mutlu Hizal
- Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, 06800, Turkey
| | - Burcu Gulbagci
- Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, 54187, Turkey
| | - Nail Paksoy
- Department of Medical Oncology, Istanbul University, Istanbul, 34093, Turkey
| | - Sena Ece Davarci
- Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar, 03200, Turkey
| | - Funda Yilmaz
- Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, 06200, Turkey
| | - Ozlem Dogan
- Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, 06170, Turkey
| | - Sibel Oyucu Orhan
- Department of Medical Oncology, Uludag University, Bursa, 16059, Turkey
| | - Erkan Kayikcioglu
- Department of Medical Oncology, Suleyman Demirel University, Isparta, 32260, Turkey
| | - Ali Aytac
- Department of Medical Oncology, Aydin Adnan Menderes University Training & Research Hospital, Aydin, 09100, Turkey
| | - Merve Keskinkilic
- Department of Medical Oncology, Dokuz Eylül University Research & Application Hospital, Izmir, 35340, Turkey
| | - Eda Eylemer Mocan
- Department Of Medical Oncology, Ankara University, Ankara, 06080, Turkey
| | - Olcun Umit Unal
- Department of Medical Oncology, Tepecik Training & Research Hospital, Izmir, 35180, Turkey
| | - Esra Aydin
- Department of Medical Oncology, Recep Tayyip Erdoğan University Training & Research Hospital, Rize, 53020, Turkey
| | - Hakan Yucel
- Department of Medical Oncology, Gaziantep University, Gaziantep, 27580, Turkey
| | - Deniz Isik
- Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, 41140, Turkey
| | - Onder Eren
- Department of Medical Oncology, Selcuk University Medical Faculty Hospital, Konya, 42250, Turkey
| | - Basak Oyan Uluc
- Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, 34750, Turkey
| | - Melike Ozcelik
- Department of Medical Oncology, Umraniye Training & Research Hospital, Istanbul, 34764, Turkey
| | - Ilhan Hacibekiroglu
- Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, 54187, Turkey
| | - Adnan Aydiner
- Department of Medical Oncology, Istanbul University, Istanbul, 34093, Turkey
| | - Hacer Demir
- Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar, 03200, Turkey
| | - Berna Oksuzoglu
- Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, 06200, Turkey
| | - Ebru Cilbir
- Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, 06170, Turkey
| | - Erdem Cubukcu
- Department of Medical Oncology, Uludag University, Bursa, 16059, Turkey
| | - Bulent Cetin
- Department of Medical Oncology, Suleyman Demirel University, Isparta, 32260, Turkey
| | - Esin Oktay
- Department of Medical Oncology, Aydin Adnan Menderes University Training & Research Hospital, Aydin, 09100, Turkey
| | - Cihan Erol
- Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, 06800, Turkey
| | - Sadi Kerem Okutur
- Department of Medical Oncology, Istanbul Arel University, Bahcelievler Memorial Hospital, Istanbul, 34537, Turkey
| | - Nilgun Yildirim
- Department of Medical Oncology, Firat University Hospital, Elazig, 23200, Turkey
| | - Ali Alkan
- Department of Medical Oncology, Muğla Sıtkı Koçman University Training & Research Hospital, Mugla, 48000, Turkey
| | - Fatih Selcukbiricik
- Department of Medical Oncology, Koç University Hospital, Istanbul, 34010, Turkey
| | - Asude Aksoy
- Department of Medical Oncology, Elazig Fethi Sekin City Hospital, Elazig, 23280, Turkey
| | - Yusuf Karakas
- Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, 48420, Turkey
| | - Gulhan Ozkanli
- Department of Medical Oncology, Canakkale Onsekiz Mart University Research & Practice Hospital, Canakkale, 17100, Turkey
| | - Berna Bozkurt Duman
- Department of Medical Oncology, Adana City Training & Research Hospital, Adana, 01230, Turkey
| | - Dincer Aydin
- Department of Medical Oncology, Kocaeli Derince Training & Research Hospital, Kocaeli, 41310, Turkey
| | - Ozgecan Dulgar
- Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras, 46050, Turkey
| | - Muhammed Muhiddin Er
- Department of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, 42080, Turkey
| | - Fatih Teker
- Department of Medical Oncology, Gaziantep University, Gaziantep, 27580, Turkey
| | - Tugba Yavuzsen
- Department of Medical Oncology, Dokuz Eylül University Research & Application Hospital, Izmir, 35340, Turkey
| | - Musa Baris Aykan
- Department of Medical Oncology, Gulhane Training & Research Hospital, Ankara, 06010, Turkey
| | - Ali Inal
- Department of Medical Oncology, Mersin City Hospital, Mersin, 96015, Turkey
| | - Yakup Iriagac
- Department of Medical Oncology, Namik Kemal University Health Application & Research Hospital, Tekirdag, 59030, Turkey
| | - Nurhan Onal Kalkan
- Department of Medical Oncology, Van Yüzüncü Yıl University Dursun Odabas Hospital, Van, 65090, Turkey
| | - Murat Keser
- Department of Medical Oncology, Tepecik Training & Research Hospital, Izmir, 35180, Turkey
| | - Teoman Sakalar
- Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras, 46050, Turkey
| | - Serkan Menekse
- Department of Medical Oncology, Manisa City Hospital, Manisa, 45040, Turkey
| | - Engin Kut
- Department of Medical Oncology, Manisa City Hospital, Manisa, 45040, Turkey
| | - Burak Bilgin
- Department of Medical Oncology, Konya City Hospital, Konya, 42020, Turkey
| | - Muge Karaoglanoglu
- Department of Medical Oncology, Ordu State Hospital, Ordu, 52200, Turkey
| | - Veli Sunar
- Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, 09020, Turkey
| | - Ozlem Ozdemir
- Department of Medical Oncology, Izmir Bozyaka Training & Research Hospital, Izmir, 35170, Turkey
| | - Nazim Serdar Turhal
- Department of Medical Oncology, Anadolu Medical Center, Istanbul, 34758, Turkey
| | - Nuri Karadurmus
- Department of Medical Oncology, Gulhane Training & Research Hospital, Ankara, 06010, Turkey
| | - Bulent Yalcin
- Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, 06800, Turkey
| | - Mehmet Ali Nahit Sendur
- Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, 06800, Turkey
| |
Collapse
|
2
|
Özdemir Ö, Zengel B, Yildiz Y, Uluç BO, Cabuk D, Ozden E, Salim DK, Paydas S, Demir A, Diker O, Pilanci KN, Sönmez ÖU, Vatansever S, Dogan I, Gulmez A, Cakar B, Gursoy P, Yildirim ME, Ayhan M, Karadurmus N, Aykan MB, Cevik GT, Sakalar T, Hacibekiroglu I, Gülbagci BB, Dincer M, Garbioglu DB, Kemal Y, Nayir E, Taskaynatan H, Yilmaz M, Avci O, Sari M, Coban E, Atci MM, Esen SA, Telli TA, Karatas F, Inal A, Demir H, Kalkan NO, Yilmaz C, Tasli F, Alacacioglu A. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs 2022; 33:663-670. [PMID: 35703239 DOI: 10.1097/cad.0000000000001310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted by the Turkish Oncology Group (TOG) with data collected from 32 centers. Our study was multicentric, and a total of 364 patients were included. The median age of the patients was 49 years (18-85 years). Two hundred fifteen (60%) of the cases were hormone receptor/HER2+ positive(ER+ or PR+, or both), and 149 (40%) of them were HER2-rich (ER and PR negative). The number of complete responses was 124 (54%) in the docetaxel+trastuzumab+pertuzumab arm and 102 (45%) in the paclitaxel+trastuzumab+pertuzumab arm, and there was no difference between the groups in terms of complete response. In 226 (62%) patients with complete response, a significant correlation was found with DCIS, tumor focality, removed lymph node, and ER status P < 0.05. Anemia, nausea, vomiting, myalgia, alopecia, and mucosal inflammation were significantly higher in the docetaxel arm, P < 0.05. In our study, no statistical difference was found between the before-after echocardiography values. DCIS positivity in biopsy before neoadjuvant chemotherapy, tumor focality; the number of lymph nodes removed and ER status were found to be associated with pCR. In conclusion, we think that studies evaluating pCR-related clinicopathological variables and radiological imaging features will play a critical role in the development of nonsurgical treatment approaches.
Collapse
Affiliation(s)
| | - Baha Zengel
- General Surgery, Bozyaka Training and Research Hospital
| | - Yaşar Yildiz
- Department Medical of Oncology, Katip Çelebi University, Atatürk Training and Research Hospital, Izmir
| | | | - Devrim Cabuk
- Department of Medical Oncology, Kocaeli University Faculty of Medicine Hospital, Kocaeli
| | - Ercan Ozden
- Department of Medical Oncology, Kocaeli University Faculty of Medicine Hospital, Kocaeli
| | - Derya Kivrak Salim
- Department of Medical Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya
| | - Semra Paydas
- Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Atakan Demir
- Department of Medical Oncology, Acibadem Hospital, Istanbul
| | - Omer Diker
- Department of Medical Oncology, Near East University Hospital, Lefkosa, Cyprus
| | | | | | - Sezai Vatansever
- Department of Medical Oncology, Istanbul University Faculty of Medicine, Istanbul
| | - Izzet Dogan
- Department of Medical Oncology, Istanbul University Faculty of Medicine, Istanbul
| | - Ahmet Gulmez
- Department of Medical Oncology, Inonu University Faculty of Medicine, Malatya
| | - Burcu Cakar
- Department of Medical Oncology, Ege University Faculty of Medicine, Izmir
| | - Pinar Gursoy
- Department of Medical Oncology, Ege University Faculty of Medicine, Izmir
| | | | - Murat Ayhan
- Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul
| | - Nuri Karadurmus
- Department of Medical Oncology, Health Sciences University Gulhane Training and Research Hospital, Ankara
| | - Musa Baris Aykan
- Department of Medical Oncology, Health Sciences University Gulhane Training and Research Hospital, Ankara
| | - Gökcen Tugba Cevik
- Department of Medical Oncology, Usak University Training and Research Hospital, Usak
| | - Teoman Sakalar
- Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras
| | - Ilhan Hacibekiroglu
- Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya
| | - Burcu Belen Gülbagci
- Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya
| | - Murat Dincer
- Department of Medical Oncology, Osmangazi University Faculty of Medicine Hospital, Eskisehir
| | - Duygu Bayir Garbioglu
- Department of Medical Oncology, Osmangazi University Faculty of Medicine Hospital, Eskisehir
| | - Yasemin Kemal
- Department of Medical Oncology, Medical Park Hospital, Samsun
| | - Erdinc Nayir
- Department of Medical Oncology, Medical Park Hospital, Mersin
| | | | - Mesut Yilmaz
- Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Istanbul
| | - Okan Avci
- Department of Medical Oncology, Namik Kemal University Hospital, Tekirdag
| | - Murat Sari
- Department of Medical Oncology, Haydarpaşa Numune Training and Research Hospital
| | - Ezgi Coban
- Department of Medical Oncology, Haydarpaşa Numune Training and Research Hospital
| | | | | | - Tugba Akin Telli
- Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul
| | - Fatih Karatas
- Department of Medical Oncology, Karabuk University Faculty of Medicine, Karabuk
| | - Ali Inal
- Department of Medical Oncology, Mersin City Training and Research Hospital, Mersin
| | - Hacer Demir
- Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar
| | - Nurhan Onal Kalkan
- Department of Medical Oncology, Van Yuzuncu Yil Faculty of Medicine, Van
| | | | - Funda Tasli
- Department of Pathology, Bozyaka Training and Research Hospital, Izmir, Turkey
| | - Ahmet Alacacioglu
- Department Medical of Oncology, Katip Çelebi University, Atatürk Training and Research Hospital, Izmir
| |
Collapse
|